(Q56342047)

English

Tafenoquine receives regulatory approval in U.S. for prophylaxis of malaria and radical cure of Plasmodium vivax

scholarly article by Kathrine R Tan & Jimee Hwang published 20 August 2018 in Journal of Travel Medicine

Statements

Tafenoquine receives regulatory approval in U.S. for prophylaxis of malaria and radical cure of Plasmodium vivax (English)
0 references
0 references
0 references
Kathrine R Tan
0 references
Jimee Hwang
0 references
20 August 2018
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit